Makes the words on every page larger.
PIP & disability benefits

PIP for Crohn's and IBD, how to claim

Updated 2 November 2026. How we check our sources.

General information, not benefits advice. For IBD the anchors are usually the continence activity and the activity for managing therapy or monitoring a health condition, which includes managing medication. Frame the claim around flare frequency, urgent bathroom access, and the biologic regimen.

Does Crohn's / UC qualify?

Yes. Crohn's disease (NG129) and ulcerative colitis (NG130) are recognised long-term conditions. The PIP test is functional impact, and both conditions commonly hit continence, food handling, therapy management and mobility in flare and recovery.

The continence descriptor

DL 5 (managing toilet needs / continence) is the anchor for IBD claims:

  • Needs to use an aid or appliance (stoma bag, incontinence pads): 2 points.
  • Needs supervision or prompting to be able to manage toilet needs: 2 points.
  • Needs assistance to manage toilet needs: 4 points.
  • Needs assistance to manage incontinence of either bladder or bowel: 6 points.
  • Needs assistance to manage incontinence of both bladder and bowel: 8 points.

Under Reg 7 apply the 50 per cent rule across the 12 month period: flare frequency and severity determine which descriptor is majority.

Biologics and Daily Living 3

DL 3 (managing therapy or monitoring a health condition) covers medication as well as therapy. Schedule 1 does not count taking or administering medication as "therapy", so help with the medicines below is descriptor 3b (1 point): needing an aid or appliance, or supervision, prompting or assistance, to manage medication or to monitor a health condition. Include:

  • Biologics: infliximab (IV infusions on 8-week cycles), adalimumab / golimumab (self-injection), vedolizumab, ustekinumab, risankizumab.
  • Immunosuppressants: azathioprine, mercaptopurine, methotrexate.
  • JAK inhibitors: tofacitinib, upadacitinib.
  • Steroid tapers, aminosalicylates (mesalazine).
  • Regular monitoring bloods (FBC, LFTs, CRP, calprotectin), TB screening pre-biologic.

Which descriptors apply

  • Daily Living 5 (managing toilet needs): anchor descriptor (see above).
  • Daily Living 3 (managing therapy or monitoring a health condition): biologics and other medication, and monitoring (see above).
  • Daily Living 1 (preparing food): fatigue in flare, restricted diet, low-residue prep, cannot stand at hob during flare.
  • Daily Living 2 (taking nutrition): tube feeding through a pump or other rate-limiting device (what Schedule 1 calls a therapeutic source), needs prompting to eat.
  • Daily Living 4 (washing / bathing): around a stoma, appliance care, skin protection.
  • Mobility 1 (planning and following a journey): cannot travel without guaranteed bathroom access; cannot follow a journey alone in flare.
  • Mobility 2 (moving around): distance limited by pain, urgency, and fatigue.

Evidence to send

  • Gastroenterology clinic letter with diagnosis (Crohn's or UC), disease extent, and current treatment.
  • Colonoscopy / MRE report where available.
  • Biologics prescription and infusion schedule; IBD nurse specialist letter.
  • Stoma nurse letter and appliance regimen where applicable.
  • 4 to 8 week flare and toilet-frequency diary.
  • Recent bloods (FBC, CRP, faecal calprotectin).

At the assessment

Answer for typical days across a 12-month period, not for the good week between infusions. State how often you have accidents, how many toilet trips per day, and how often flares happen. Bring an advocate.

The four-point rule (scrapped)

You may have read about a four-point rule starting in November 2026. It was removed from the bill in July 2025 and never became law. PIP rules are unchanged while the Timms Review runs (expected to report around autumn 2026). Evidence in descriptor and reliability language remains what decides awards.

Frequently asked questions

Can you get PIP for Crohn's or ulcerative colitis?

Yes. IBD can affect several PIP activities. Continence, therapy management, food preparation and mobility are all commonly affected in flare. NG129 (Crohn's) and NG130 (UC) are the NHS anchors.

Do I have to be in flare all the time?

No. Under the 50 per cent rule (Reg 7) a descriptor applies if it fits on more than half of days over 12 months. Long flare periods, urgent bathroom access, fatigue, and post-biologic infusion recovery days all count.

Which activities does IBD score on most?

Most commonly: DL 5 managing toilet needs / continence, DL 3 managing medication (biologics, immunosuppressants), DL 1 preparing food (restricted diet, fatigue), Mob 1 planning a journey (bathroom access), DL 2 taking nutrition (tube feeding, or needing prompting to eat).

Does a stoma affect the claim?

Yes. A stoma is relevant to DL 5, because Schedule 1 defines managing incontinence to include using a collecting device. Needing an aid or appliance is descriptor 5b (2 points), and needing assistance to manage incontinence of either bladder or bowel is descriptor 5e (6 points). It also affects DL 4 washing and DL 6 dressing (bag placement, appliance changes, skin care).

Do biologics count as complex therapy?

Not as therapy. Schedule 1 to the PIP Regulations excludes taking or administering medication, by any means, from "therapy", so infliximab, adalimumab, vedolizumab, ustekinumab and JAK inhibitors count as medication. Help with them is descriptor 3b, "supervision, prompting or assistance to be able to manage medication", which carries 1 point. Include infusion schedules, injection training and monitoring bloods on your form.

General information and document drafting, not benefits advice. Finally Seen is not affiliated with DWP or the NHS and does not guarantee any award. Check current guidance at gov.uk before sending.

Use Google? Add Finally Seen as a preferred source and Google is more likely to show you our pages.

Related guides

Last updated 2 November 2026 · Sources re-audited 7 July 2026 · How we research · Spot an inaccuracy? Email us

About Finally Seen · Sources cited inline, dated at update · Not medical or benefits advice